The Problem
Cancer is usually detected in late stages
A vast majority of cancers show no symptoms until late stages, when treatment is complex, painful, traumatic, with poor clinical outcomes and financially toxic.
Cancer is usually detected in late stages
A vast majority of cancers show no symptoms until late stages, when treatment is complex, painful, traumatic, with poor clinical outcomes and financially toxic.
India’s cancer reality
> 0.9 mil new cancer patients each year do not have access to any cancer screening solution
*Source: Globocan 2020
India’s cancer screening gap needs closure as it is the main cause for late stage detection of cancer where treatment becomes difficult or impossible
India’s cancer reality
> 0.9 mil new cancer patients each year do not have access to any cancer screening solution
*Source: Globocan 2020
India’s cancer screening gap needs closure as it is the main cause for late stage detection of cancer where treatment becomes difficult or impossible
The Solution
PanTum® Detect - A multi-tumor screening blood test for asymptomatic healthy individuals
“Cancer-Scan" program combines blood testing with advanced imaging techniques into an integrated multi tumor screening concept for detection of cancer and pre-cancerous lesions in early and symptomless stages for healthy individuals.
The best remedy for cancer is to never let it advance in the first place
Give life a chance
Multi Tumor Screening test for Asymptomatic Healthy Population
Don't wait for onset of symptom's
KNOW IT NOW
Innovative & Unique
The EDIM technology is backed by science and more than 20 years of research
Leveraging the immune system to deliver high accuracy of PanTum® Detect test
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes/Macrophages) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.
Leveraging the immune system to deliver high accuracy of PanTum® Detect test
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes/Macrophages) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.
Don't wait for onset of symptoms
KNOW IT NOW
A Simple, Safe & Accurate Blood Test
Candidate’s journey through Cancer-Scan program
Connect with us for any queries
Connect with us for any queries
Useful Links
Support
Locate Us
© 2023. All rights reserved